跳至主要内容
临床试验/IRCT20210513051276N1
IRCT20210513051276N1招募中2 期

Clinical trial of Comparison of the efficacy and safety of finasteride and hydroxy chloroquine on frontal fibrosing severity index in patients with frontal fibrosing alopecia

Esfahan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • New cases with FFA who have not yet received any medication.
  • Patients who have previously received systemic therapy and have not received systemic medication for at least the last three months and according to clinical and dermoscopic criteria, their disease is active.
  • Patients treated with topical medication and according to clinical and dermoscopic criteria, their disease is active

排除标准

  • Pregnancy or lactation
  • History of hypersensivity due to hydroxychloroquine or finasteride
  • Patients with severe blood dyscrasia and liver dysfunction
  • Patients with retinopathy
  • Personal history or family history of breast cancer

研究者

相似试验

The effect of finasteride and hydroxy chloroquine on... | 临床试验